Biocryst Pharmaceuticals Income Statement (2010-2015) | BCRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2010 Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015
Revenue & cost
Revenue 12.00M16.69M5.43M5.25M5.22M-1.16M-1.16M3.55M0.82M2.39M10.57M3.46M1.47M3.24M5.45M6.83M21.78M10.99M
Cost of Revenue 0.08M0.02M0.07M0.01M0.04M0.06M0.44M1.35M
Gross Profit 0.74M10.55M3.38M1.46M5.40M6.77M21.34M9.64M
Operating items
Research & Development 19.20M25.05M12.93M14.77M15.21M7.21M7.74M15.47M9.18M11.07M13.04M18.51M17.12M16.52M20.07M
Selling, General & Administrative 3.79M1.95M4.00M3.28M1.05M1.58M1.58M1.42M1.59M2.01M1.81M2.05M4.06M3.53M2.73M
Other Operating Expenses 0.08M0.02M0.07M0.01M0.04M0.07M0.44M1.35M
Operating Expenses 22.99M27.00M16.93M18.05M16.27M8.87M9.31M16.90M10.84M13.09M14.85M20.60M21.26M20.50M24.15M
Operating Income -10.99M-10.31M-11.50M-12.80M-11.04M-5.00M-10.18M-5.32M-12.14M-6.92M-6.33M-7.39M-11.62M-11.61M-15.16M-14.43M5.34M-13.16M
EBIT -10.99M-10.31M-11.50M-12.80M-11.04M-5.00M-10.18M-5.32M-12.14M-6.92M-6.33M-7.39M-11.62M-11.61M-15.16M-14.43M5.34M-13.16M
Non-operating items
Interest & Investment Income 0.13M0.11M0.10M0.09M0.08M0.07M0.06M0.03M0.02M0.02M0.02M0.02M0.02M0.01M0.04M0.12M0.12M0.13M
Other Non Operating Income -1.34M-0.59M-1.07M0.04M-1.00M1.96M1.11M0.10M2.13M-1.53M-1.82M4.08M4.75M0.46M0.75M-0.35M
Net income details
EBT -10.86M-10.20M-11.69M-13.87M-12.12M-6.09M-11.28M-6.46M-13.29M-8.10M-7.55M-8.61M-12.82M-12.81M-16.43M-15.63M4.15M-14.27M
Profit After Tax -10.86M-10.20M-13.03M-14.46M-13.19M-6.05M-12.28M-11.05M-4.51M-12.17M-8.00M-5.43M-10.14M-14.65M-8.73M-11.67M-15.16M4.90M-14.62M
Income from Continuing Operations -10.86M-10.20M-11.69M-13.87M-12.12M-6.09M-11.28M-6.46M-13.29M-8.10M-7.55M-8.61M-12.82M-12.81M-16.43M-15.63M4.15M-14.27M
Consolidated Net Income -10.86M-10.20M-11.69M-13.87M-12.12M-6.09M-11.28M-6.46M-13.29M-8.10M-7.55M-8.61M-12.82M-12.81M-16.43M-15.63M4.15M-14.27M
Income towards Parent Company -10.86M-10.20M-11.69M-13.87M-12.12M-6.09M-11.28M-6.46M-13.29M-8.10M-7.55M-8.61M-12.82M-12.81M-16.43M-15.63M4.15M-14.27M
Net Income towards Common Stockholders -10.86M-10.20M-11.69M-13.87M-12.12M-6.09M-11.28M-6.46M-13.29M-8.10M-7.55M-8.61M-12.82M-12.81M-16.43M-15.63M4.15M-14.27M
Additional items
EPS (Basic) -0.24-0.23-0.29-0.32-0.29-0.13-0.25-0.22-0.09-0.23-0.14-0.09-0.17-0.23-0.12-0.16-0.210.07-0.20
EPS (Weighted Average and Diluted) -0.17-0.18-0.22-0.20-0.19
Shares Outstanding (Weighted Average) 44.92M44.92M45.10M45.15M45.21M46.04M49.17M50.49M50.88M50.93M53.15M54.24M59.09M59.38M60.06M71.76M71.86M72.32M72.52M73.24M
Shares Outstanding (Diluted Average) 71.80M72.34M73.26M
EBITDA -10.99M-10.31M-13.05M-12.80M-11.04M-6.04M-12.29M-4.52M-12.18M-8.01M-5.43M-10.14M-14.65M-8.73M-11.80M-15.02M4.80M-14.53M
Interest Expenses 0.29M1.16M1.16M1.16M1.16M1.18M1.17M1.19M1.24M1.24M1.23M1.22M1.31M1.31M1.31M1.24M